Gliadel Ad Features Misleading Efficacy Claims – DDMAC
This article was originally published in The Pink Sheet Daily
Executive Summary
Two-page journal ad includes unsubstantiated claims that high-grade malignant melanoma treatment “works at day 1,” FDA says.